Kyle Trudeau

Company: Sana Biotechnology

Job title: Senior Director, Co- Head of Innovation

Seminars:

Developing In Vivo Editing To Target HSCs 11:30 am

Describing how Sana’s Retargetable Fusogen platform directly couples receptor recognition to cell entry, in contrast to endosomal escape delivery systems, enabling high on vs. off-target cell specificity in vitro and in vivo Showing development of a T cell-specific fusogen to enable in vivo CAR-T therapy Highlighting data showing the progression of HSC in vivo gene…Read more

day: Conference Day One